

About Diality
Diality Inc., founded in 2013 and headquartered in Irvine, California, is a privately held medical device company committed to advancing kidney disease care. Its flagship product, the Moda-flx Hemodialysis System, is a smart, flexible, portable, and home-based dialysis device designed to improve patient outcomes and reduce the burden of care. The company’s mission is to enhance the quality of life for patients while enabling more access to home dialysis solutions.
Core Business & Key Technologies
Diality specializes in the research, development, and commercialization of advanced hemodialysis systems. The Moda-flx Hemodialysis System integrates reverse osmosis (RO) water filtration, offers dialysis flow rates up to 600 mL/min, and features a user-friendly graphical interface. Its compact and mobile design ensures seamless integration across acute, post-acute, and chronic care facilities. With a cloud-based portal for data collection and treatment personalization, the system supports multiple therapies including IHD, SLED/SLEDD, and PIRRT.
Market Position & Flagship Products
Diality’s Moda-flx Hemodialysis System received FDA 510(k) clearance in August 2024 for professional use and is undergoing clinical trials for home use under the PRESCRIBE Diality program. The system bridges the gap between in-center and home hemodialysis technologies by combining advanced prescription flexibility with next-generation ease of use. Backed by $112 million in funding, including $28 million in Series C (2023), Diality is positioned among innovators like Quanta, Outset Medical, and NxStage. As of 2025, its annual revenue is estimated at $32.4 million.
Recent Developments
In September 2025, Diality initiated its first patient treatment in the PRESCRIBE Diality Home Hemodialysis Clinical Trial with aQua Research Institute and aQua Dialysis in Houston, Texas. Earlier, in August 2024, the Moda-flx Hemodialysis System achieved FDA 510(k) clearance, marking a major milestone in providing clinicians with customizable dialysis care through a single integrated system.
Contact Information
Address: 181 Technology Drive STE 150, Irvine, CA 92618, USA
Phone: +1 (949) 266-9900
Keywords: Diality, Moda-flx Hemodialysis System, hemodialysis devices, kidney disease treatment, portable dialysis, home hemodialysis, reverse osmosis dialysis system
猜你喜欢
-
Outlook Surgical
Outlook Surgical, based in Vancouver, Canada, develops advan... -
Kardium Inc.
Kardium Inc., headquartered in Vancouver, Canada, develops a... -
Zimmer Biomet Holdings, Inc.
Zimmer Biomet Holdings, Inc., headquartered in Warsaw, India... -
Ningbo Sunny Instruments CO.,LTD.
Ningbo Sunny Instruments Co., Ltd., founded in 2001 and a co... -
Eyebright Medical Technology (Beijing) Co., Ltd.
Eyebright Medical Technology (Beijing) Co., Ltd., founded in... -
Neuromod Devices Ltd.
Neuromod Devices Ltd., founded in 2010 and headquartered in... -
Smartsound Corporation
Smartsound Corporation, founded in 2011 in South Korea... -
Sigma-Laborzentrifugen GmbH
Sigma-Laborzentrifugen GmbH, founded in 1975 in Germany, is... -
Siemens Healthcare GmbH
Siemens Healthcare GmbH, a subsidiary of Siemens AG, is a le... -
RISTEK INSTRUMENTS
RISTEK INSTRUMENTS, based in Sialkot, Pakistan, manufactures... -
Brainlab AG
Brainlab AG, founded in 1989 in Munich, is a global leader i... -
Medline Industries
Medline Industries, LP OverviewMedline Industries, LP, found...
网友评论
- 热门标签
-
- USA
- California
- Germany
- China
- Florida
- France
- Shanghai
- New York
- Zhejiang
- Canada
- British Columbia
- Medtronic
- Robocath
- Massachusetts
- Mentor
- Johnson
- Ningbo
- Munich
- Zimmer
- Michigan
- Korea
- Seoul
- Indiana
- enVVeno
- Hangzhou
- Sprin
- Rula
- Included
- Lyra
- Noom
- Amwell
- Philips
- CooperVision California
- Abbott
- Given
- Yokneam
- Israel
- Pulse
- PillSafe
- Oklahoma
- Dublin
- Pakistan
- Siemens
- Sigma-Laborzentrifugen
- Harz
- Smartsound
- Neuromod
- Kardium
- Sunny
- Beijing
- 关注我们
-
扫一扫二维码关注我们的微信公众号